Danyelly Martins

Prof. Danyelly Martins

Universidade Federal de Pernambuco (Federal University of Pernambuco), Recife 50670-901, Brazil
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
RGR.L.N. Godone
R.L.N. Godone
GLG.M. Leitão
G.M. Leitão
NAN.B. Araújo
N.B. Araújo
CCC.H.M. Castelletti
C.H.M. Castelletti
JLJ.L. Lima-Filho
J.L. Lima-Filho
DMDanyelly Martins
Danyelly Martins

26 May 2011 in Sensors
Verified
Journal Article
Open access
PDF file
ESElaine Souza
Elaine Souza
GNGustavo Nascimento
Gustavo Nascimento
NSNataly Santana
Nataly Santana
DFDanielly Ferreira
Danielly Ferreira
MLManoel Lima
Manoel Lima
JLJosé Lima-Filho
José Lima-Filho
A biosensor that relies on the adsorption immobilization of the 18-mer single-stranded nucleic acid related to dengue virus gene 1 on activated pencil graphite was developed. Hybridization between the probe and its complementary oligonucleotides (the target) was investigated by monitoring guanine oxidation by differential pulse voltammetry (DPV). The pencil graphite electrode was made of ordinary pencil lead (type 4B). The polished surface of the working electrode was activated by applying a potential of 1.8 V for 5 min. Afterward, the dengue oligonucleotides probe was immobilized on the activated electrode by applying 0.5 V to the electrode in 0.5 M acetate buffer (pH 5.0) for 5 min. The hybridization process was carried out by incubating at the annealing temperature of the oligonucleotides. A time of five minutes and concentration of 1 μM were found to be the optimal conditions for probe immobilization. The electrochemical detection of annealing between the DNA probe (TS-1P) immobilized on the modified electrode, and the target (TS-1T) was achieved. The target could be quantified in a range from 1 to 40 nM with good linearity and a detection limit of 0.92 nM. The specificity of the electrochemical biosensor was tested using non-complementary sequences of dengue virus 2 and 3.

1 October 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
AOAna Cecília de Albuquerque Oliveira
Ana Cecília de Albuquerque Oliveira
FKFerdinand Kappes
Ferdinand Kappes
DMDanyelly Martins
Danyelly Martins
JFJosé Luiz de Lima Filho
José Luiz de Lima Filho

17 August 2011 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
MCMaria das Graças F. C. Castor
Maria das Graças F. C. Castor
HSHilton Justino da Silva
Hilton Justino da Silva
DMDanyelly Martins
Danyelly Martins
RMRoberto José Vieira de Mello
Roberto José Vieira de Mello

1 January 2015 in Genetics and Molecular Research
Verified
Journal Article
Open access
APA.L. Peres
A.L. Peres
JCJ.R.S.L. Camarotti
J.R.S.L. Camarotti
MCM. Cartaxo
M. Cartaxo
NAN. Alencar
N. Alencar
RSR.C. Stocco
R.C. Stocco
DMDanyelly Martins
Danyelly Martins
We investigated the association between bacterial vaginosis (BV) and human papillomavirus (HPV) infection in Papanicolaou smears in a Brazilian population. Cross-sectional analysis was performed on 673 samples collected from women attending public health centers in Olinda (PE, Brazil) by conventional cytology methodology and molecular analysis, PCR tests (GP5+/6+ and MY09/11). Cytological abnormalities, BV, and HPV-DNA were detected in 23 (3.4%) samples, 189 samples (28.1%), and 210 samples (31.2%), respectively. GP5+/6+ primers resulted in higher detection performance than MY09/11 primers, with 81% concordance between both primers (P < 0.0001). The occurrence of HPV-DNA and BV had ORs of 8.59 (P < 0.0001) and 2.91 (P = 0.0089) for abnormal cytology, respectively, whereas the concomitant presence of both infections showed an OR equal to 3.82 (P = 0.0054). Therefore, we observed an association between abnormal cervical cytology and HPV infection, BV, or both HPV infection and BV. These results highlight the necessity of monitoring patients presenting not only HPV, but also BV, as risk factors for cervical lesion development.

1 October 2020 in Breast Cancer: Targets and Therapy
Verified
Journal Article
Open access
PDF file
ASAlexandre Cesar Vieira Sales
Alexandre Cesar Vieira Sales
ISIsaura Isabelle Fonseca Gomes da Silva
Isaura Isabelle Fonseca Gomes da Silva
MLMatheus Cb Leite
Matheus Cb Leite
LCLeandro L Coutinho
Leandro L Coutinho
RRRenata Bac Reis
Renata Bac Reis
FSFabricio Oliveira Souto
Fabricio Oliveira Souto
Introduction: MicroRNA-21 (miRNA-21) has been described as one of the most significantly upregulated miRNAs in human breast cancer. However, limited knowledge exists on miRNA-21 expression in breast cancer tissue after neoadjuvant chemotherapy (NAC). Purpose: The aim of this study was to assess miRNA-21 expression in the tumor tissues of Brazilian patients with breast cancer who underwent NAC and its correlation with clinicopathological variables. Patients and Methods: Utilizing qRT-PCR, miRNA-21 expression in tumor tissue was measured in a cohort of female patients with breast cancer who underwent NAC. The correlation of miRNA-21 expression with breast cancer molecular subtypes and other clinicopathological variables was also assessed. Results: A total of 55 patients were included in the study, and 28 (50.9%) underwent NAC. miRNA-21 was upregulated in patients with breast cancer, regardless of previous exposure to chemotherapy, molecular subtypes, tumor-node-metastasis (TNM) staging and lymph node status of the axilla. miRNA-21 expression did not differ between patients with breast cancer who achieved a pathologic complete response after NAC and healthy controls. Conclusion: miRNA-21 was upregulated in the tumor tissue of Brazilian patients with breast cancer regardless of NAC treatment, which reinforces its role as an “oncomiR” and a potential biomarker.